Employees: 11 (2023.0)Legal category: 5485Size: PMECreation date: 2014-06-03 (11 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: LA VERPILLIERE (38290), Isere
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
GRANDE PHARMACIE DE LA REPUBLIQUE : revenue, balance sheet and financial ratios
GRANDE PHARMACIE DE LA REPUBLIQUE is a French company
founded 11 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in LA VERPILLIERE (38290),
this company of category PME
shows in 2024 a net income positive of 123 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - GRANDE PHARMACIE DE LA REPUBLIQUE (SIREN 803820083)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
123 067 €
157 659 €
286 948 €
294 340 €
168 602 €
214 793 €
182 756 €
160 197 €
62 664 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2024, GRANDE PHARMACIE DE LA REPUBLIQUE generates positive net income of 123 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 63 k€ -> 123 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
123 067 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 226%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 26%. The balance between equity and debt is satisfactory.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
225.556%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
26.029%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution GRANDE PHARMACIE DE LA REPUBLIQUE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
451.908
296.988
203.348
797.254
445.928
284.749
208.152
236.038
225.556
Financial autonomy
16.139
21.93
28.71
8.937
14.888
21.702
27.027
24.72
26.029
Repayment capacity
None
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
225.562024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Average
In 2024, the debt ratio of GRANDE PHARMACIE DE LA RE... (225.56) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
26.03%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Watch
In 2024, the financial autonomy of GRANDE PHARMACIE DE LA RE... (26.0%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 133.44. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
133.441
Liquidity indicators evolution GRANDE PHARMACIE DE LA REPUBLIQUE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
142.556
128.497
136.125
101.926
115.02
123.875
144.285
148.872
133.441
Interest coverage
None
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
133.442024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Average
In 2024, the liquidity ratio of GRANDE PHARMACIE DE LA RE... (133.44) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Positioning of GRANDE PHARMACIE DE LA REPUBLIQUE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of GRANDE PHARMACIE DE LA REPUBLIQUE is estimated at
1 718 106 €
(range 1 196 462€ - 2 570 385€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
1196k€1718k€2570k€
1 718 106 €Range: 1 196 462€ - 2 570 385€
NAF 5 année 2024
Valuation method used
Net Income Multiple
123 067 €
×
14.0x
=1 718 106 €
Range: 1 196 462€ - 2 570 385€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare GRANDE PHARMACIE DE LA REPUBLIQUE with other companies in the same sector:
Frequently asked questions about GRANDE PHARMACIE DE LA REPUBLIQUE
What is the revenue of GRANDE PHARMACIE DE LA REPUBLIQUE ?
The revenue of GRANDE PHARMACIE DE LA REPUBLIQUE is not publicly disclosed (confidential accounts filed with INPI).
Is GRANDE PHARMACIE DE LA REPUBLIQUE profitable?
Yes, GRANDE PHARMACIE DE LA REPUBLIQUE generated a net profit of 123 k€ in 2024.
Where is the headquarters of GRANDE PHARMACIE DE LA REPUBLIQUE ?
The headquarters of GRANDE PHARMACIE DE LA REPUBLIQUE is located in LA VERPILLIERE (38290), in the department Isere.
Where to find the tax return of GRANDE PHARMACIE DE LA REPUBLIQUE ?
The tax return of GRANDE PHARMACIE DE LA REPUBLIQUE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does GRANDE PHARMACIE DE LA REPUBLIQUE operate?
GRANDE PHARMACIE DE LA REPUBLIQUE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart